Sb Investment Advisers (Uk) LTD Relay Therapeutics, Inc. Transaction History
Sb Investment Advisers (Uk) LTD
- $13.2 Billion
- Q3 2025
A detailed history of Sb Investment Advisers (Uk) LTD transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Sb Investment Advisers (Uk) LTD holds 27,904,963 shares of RLAY stock, worth $185 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
27,904,963
Previous 27,904,963
-0.0%
Holding current value
$185 Million
Previous $96.6 Million
50.87%
% of portfolio
1.1%
Previous 0.77%
Shares
1 transactions
Others Institutions Holding RLAY
# of Institutions
215Shares Held
168MCall Options Held
714KPut Options Held
14.9K-
Commodore Capital LP New York, NY17MShares$113 Million5.66% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct14.8MShares$97.8 Million0.15% of portfolio
-
Casdin Capital, LLC New York, NY11.3MShares$75.1 Million8.07% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$69.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.4MShares$62.2 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $796M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...